Catalog No.
KAD17201
Description
PRINCIPLE OF THE ASSAY This assay employs the quantitative sandwich enzyme immunoassay technique. Ipilimumab has been pre-coated onto a microplate. Samples or standards are pipetted into microwells and Anti-Ipilimumab will be captured by immobilized Ipilimumab. After washing away any unbound substances, a biotin-labeled Ipilimumab is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Anti-Ipilimumab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Applications
Used for the quantitative determination of Anti-Ipilimumab concentration in serum and plasma.
Detection method
Colorimetric
Sample type
Plasma, Serum
Assay type
Quantitative
Range
7.81 - 500 ng/mL
Sensitivity
4.25 ng/mL
Precision
Intra-Assay Precision (Precision within an assay): <10%
Three samples of known concentration were tested sixteen times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): <15%
Three samples of known concentration were tested in twenty four separate assays to assess inter-assay precision.
|
Intra-Assay Precision |
Inter-Assay Precision |
||||
Sample |
1 |
2 |
3 |
1 |
2 |
3 |
n |
16 |
16 |
16 |
24 |
24 |
24 |
Mean (ng/mL) |
223.4 |
60.7 |
11.8 |
225.5 |
49.1 |
12.8 |
Standard deviation |
14.0 |
3.3 |
1.1 |
14.9 |
2.8 |
1.0 |
CV (%) |
6.3 |
5.5 |
9.0 |
6.6 |
5.7 |
8.2 |
Recovery
80-120%
Shipping
2-8 ℃
Stability and Storage
When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
Alternative Names
BMS-734016,MDX-010,MDX-CTLA-4,CAS: 477202-00-9